[Comment on article "Enoxaparin dose associated with decreased risk of death in COVID-19"].

Mateo Porres-Aguilar Javier E Anaya-Ayala

Published in: Revista medica del Instituto Mexicano del Seguro Social (2022)

In this letter to the editor, apropos of the article "Enoxaparin dose associated with decreased risk of death in COVID-19", it is discussed the role of the current thromboprophylactic strategies, as well as the potential role of heparins in the management of COVID-19.

Keyphrases

coronavirus disease
sars cov
venous thromboembolism
respiratory syndrome coronavirus
risk assessment
climate change